133 related articles for article (PubMed ID: 6547791)
1. Plateletapheresis program. II. Computer selection of HLA compatible donors.
Jorgensen DW; McFarland JG; Hillman RS; Slichter SJ
Transfusion; 1984; 24(4):292-8. PubMed ID: 6547791
[TBL] [Abstract][Full Text] [Related]
2. Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients.
Duquesnoy RJ; Filip DJ; Rodey GE; Rimm AA; Aster RH
Am J Hematol; 1977; 2(3):219-26. PubMed ID: 596366
[TBL] [Abstract][Full Text] [Related]
3. A model to determine required pool size for HLA-typed community donor apheresis programs.
Bolgiano DC; Larson EB; Slichter SJ
Transfusion; 1989 May; 29(4):306-10. PubMed ID: 2718233
[TBL] [Abstract][Full Text] [Related]
4. Use of in vitro assays in selection of compatible platelet donors.
Tosato G; Appelbaum FR; Trapani RJ; Dowling R; Deisseroth AB
Transfusion; 1980; 20(1):47-54. PubMed ID: 7355471
[TBL] [Abstract][Full Text] [Related]
5. Selection of histocompatible apheresis platelet donors by cross-matching random donor platelet concentrates.
O'Connell BA; Lee EJ; Rothko K; Hussein MA; Schiffer CA
Blood; 1992 Jan; 79(2):527-31. PubMed ID: 1730095
[TBL] [Abstract][Full Text] [Related]
6. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
Levy L; Woodfield DG
N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
[TBL] [Abstract][Full Text] [Related]
7. Platelet crossmatch testing for donor selection.
Slichter SJ
Prog Clin Biol Res; 1982; 88():153-64. PubMed ID: 7100207
[TBL] [Abstract][Full Text] [Related]
8. Cost-benefit analysis of a plateletapheresis program.
McFarland JG; Larson EB; Hillman RS; Slichter SJ
Transfusion; 1986; 26(1):91-7. PubMed ID: 3080832
[TBL] [Abstract][Full Text] [Related]
9. Donor selection in platelet transfusion therapy of alloimmunized thrombocytopenic patients.
Duqesnoy RJ
Prog Clin Biol Res; 1978; 28():229-43. PubMed ID: 88057
[No Abstract] [Full Text] [Related]
10. Effective cell support by repeat plateletpheresis of related donors on the IBM 2997 cell separator.
Langley JW; Spiva D; Hendren D; Orrell J
Am J Clin Pathol; 1981 Aug; 76(2):148-54. PubMed ID: 7270495
[TBL] [Abstract][Full Text] [Related]
11. Effect of HLA Bw4/Bw6 compatibility on platelet transfusion responses of refractory thrombocytopenic patients.
McElligott MC; Menitove JE; Duquesnoy RJ; Hunter JB; Aster RH
Blood; 1982 May; 59(5):971-5. PubMed ID: 6951616
[TBL] [Abstract][Full Text] [Related]
12. Platelet transfusion from donors mismatched for crossreactive HLA antigens.
Dahlke MB; Weiss KL
Transfusion; 1984; 24(4):299-302. PubMed ID: 6464151
[TBL] [Abstract][Full Text] [Related]
13. Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity.
Petz LD; Garratty G; Calhoun L; Clark BD; Terasaki PI; Gresens C; Gornbein JA; Landaw EM; Smith R; Cecka JM
Transfusion; 2000 Dec; 40(12):1446-56. PubMed ID: 11134563
[TBL] [Abstract][Full Text] [Related]
14. Platelet transfusion: automated selection of donors.
Muller JY; Cartron JP; Trillot P; Halle L; Roquin H
Transfusion; 1981; 21(3):261-7. PubMed ID: 7233510
[TBL] [Abstract][Full Text] [Related]
15. Platelet crossmatching. A direct approach to the selection of platelet transfusions for the alloimmunized thrombocytopenic patient.
Kickler TS; Ness PM; Braine HG
Am J Clin Pathol; 1988 Jul; 90(1):69-72. PubMed ID: 3389345
[TBL] [Abstract][Full Text] [Related]
16. The relationship between donor-recipient lymphocytotoxicity and the transfusion response using HLA-matched platelet concentrates.
Herzig RH; Terasaki PI; Trapani RJ; Herzig GP; Graw RG
Transfusion; 1977; 17(6):657-61. PubMed ID: 595123
[TBL] [Abstract][Full Text] [Related]
17. Independent roles for platelet crossmatching and HLA in the selection of platelets for alloimmunized patients.
Friedberg RC; Donnelly SF; Mintz PD
Transfusion; 1994 Mar; 34(3):215-20. PubMed ID: 8146893
[TBL] [Abstract][Full Text] [Related]
18. A cost-effectiveness evaluation of platelet crossmatching and HLA matching in the management of alloimmunized thrombocytopenic patients.
Freedman J; Gafni A; Garvey MB; Blanchette V
Transfusion; 1989; 29(3):201-7. PubMed ID: 2493693
[TBL] [Abstract][Full Text] [Related]
19. Platelet transfusion therapy in an alloimmunized patient. The value of crossmatch procedures for donor selection.
Hecht T; Wolf JL; Mraz L; Scott EP; Patz LD
JAMA; 1982 Nov; 248(18):2301-3. PubMed ID: 6752444
[TBL] [Abstract][Full Text] [Related]
20. Selection of compatible platelet donors: a prospective evaluation of three cross-matching techniques.
Wu KK; Hoak JC; Koepke JA; Thompson JS
Transfusion; 1977; 17(6):638-43. PubMed ID: 145673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
